Iran's Pharmaceutical Market

It’s been many years that Iran’s pharmaceutical market has started its professional activity and today has experienced many developments. The pharmaceutical industry in our country has a 70-year history.This industry officially started its activities in Iran with the establishment of Dr. Abidi’s laboratory in 1946 and continues its activity as a product manufacturer by various companies, both domestically and internationally.

From the very beginning, there have been several factors that have put Iran’s pharmaceutical industry on the way of progress, through which the number of imported drugs is decreasing and the number of manufactured drugs is increasing day by day. According to the statistics obtained in 2021, by the terms of cost, about 87% of the drugs were domestically produced and only 13% of them were imported.

If you have got any doubts about Iran’s pharmaceutical market and you intend to know more about it,you can stay with us on this article.

In addition to introducing you the key players of pharmaceutical industry on www.pharmex.me, we are also honored to provide you with useful articles and data in order to let you know about Iran’s pharmaceutical market.

The Supply Chain of Pharmaceutical Products in Iran

When it comes to Iran’s pharmaceutical market, the Iranian industry should be examined thoroughly. In the meantime, understanding the supply chain of pharmaceutical products is very important. This chain consists of three different parts, and we will examine each them in detail.

Drug production: The first part of this chain is drug production. Generally, there are several stages in the process of drug manufacturing including initial research and development phase, obtaining a license to have the rights to sell the drug in the market, and the final phase of commercialization.

Drug distribution to the supply point: This stage of pharmaceutical products supply chain includes the transportation and management of the drug from the manufacturer to the final customer, where the final customer can be a retail supplier, such as pharmacies, hospitals or even doctors. This path is a bit complicated and totally differs between big cities and remote villages based on different factors including the location of the manufacturer, the needs to import medicine, the special needs of that location and the limitation of the end user.

Supplying to the Final Customer: The third stage of this chain is providing the proper form and size of medicine to patients. Due to the fact that this step is the final step in the supply chain of pharmaceutical products, it must be done according to a precise schedule. Of course, this stage itself includes other stages such as checking possible interactions of the drug, providing recommendations, and etc.

The Acquaintance with pharmaceutical products

We can see different sorts of pharmaceutical products in the Iranian industry, and in this regard, the classification of drugs is done separately. Generally, the classification of pharmaceutical products can be either based on their types or prescriptions. we will examine each of them in the fallowing text.

Drug classification based on the Prescription

The drugs are given with or without a prescription in this condition. Prescription drugs are the ones that require the doctor’s prescription to be obtained due to the risks of self-administration. Non-prescription medicines are the ones that are sold in pharmacies without a doctor’s prescription. Of course you should know that the list of non-prescription drugs differs between countries but generally, all kinds of food supplements, painkillers, antipyretics, antihistamines, and cough medicines are among the nonprescription medicines that can be found in Iran’s pharmaceutical market.

Iran’s Market Drugs Classification Based on Their Type

In terms of type, Drugs have two different subgroups including drugs with brand name and generic ones. Brand name drugs are available with a prescription and usually have a specific manufacturer and are more expensive in comparison with generic ones. The price difference is due to the fact that new drugs will be produced and released after research. So, the exclusive right of the manufactured drug has belonged only to its first manufacturer for many years and during this period other companies haven’t had this right to produce and supply that drug.

After expiring exclusive right of production, due to the fact that competing companies can produce the mentioned drugs at a lower cost for patients, some part of these drugs can be sold.

In the pharmaceutical market of Iran generic drugs can be also found. These drugs have generic names and any company has the right to produce and supply these sort of drugs. Generic drugs are provided at a lower price, since manufacturers in this field do not bear the high cost of research and drug manufacturing .

Strengths of Iran’s Pharmaceutical Industry

If you take a look at Iran’s pharmaceutical market, you can easily understand the strengths of this industry including:

  • Self-sufficiency in production and sales of all kinds of drugs, even orphan drugs and those related to specific diseases.
  • Increasing demand due to the age class growth and the number of elderly population.
  • Having government support for the improvement of the medical and health needs of people.
  • The Existence of effective workforce in the country for this industry.

Last but not least those who intend to enter Iran’s pharmaceutical market and work in this field as a manufacturer or seller, must acquire the necessary insights of this field in advance, which can be thoroughly examined on www.pharmex.me. Also a suitable platform for the manufacturers in order to sale their products in the International drug exhibition is provided.

No comment

Leave a Reply

Your email address will not be published. Required fields are marked *

four × three =